In The News

    • MAR 23 2017

    Dr. Varun Prabhu Recognized by Penn State University for Translation of ONC201

    The below article appeared in the January-February Edition of the Penn State University Alumni Magazine Varun Prabhu ’16 PhD IDF has been passionate about cancer research ever since he was an undergrad studying pharmaceutical science in Mumbai. He arrived at Penn State Hershey in 2010 to work on a doctorate in molecular medicine, a field

    • JAN 25 2017

    Role of GPCRs for Oncology Highlighted in “Bioscience Technology”

    In 2016, we discovered that our lead molecule, ONC201, targets a GPCR known as dopamine receptor D2 (DRD2) and that our other molecules in development also target different GPCRs.   Although GPCRs are the most common target in modern medicine (30-50% of all drugs), GPCRs have not historically been targeted in oncology.  Recently, there has been